Synergetics USA Inc  

(Public, NASDAQ:SURG)   Watch this stock  
Find more results for SURG
4.28
+0.35 (8.91%)
Dec 18 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 3.94 - 4.35
52 week 2.93 - 4.35
Open 3.95
Vol / Avg. 130,462.00/55,139.00
Mkt cap 99.66M
P/E 37.53
Div/yield     -
EPS 0.11
Shares 25.36M
Beta 1.09
Inst. own 53%
Mar 4, 2015
Q2 2015 Synergetics USA Inc Earnings Release (Estimated) Add to calendar
Dec 10, 2014
Q1 2015 Synergetics USA Inc Earnings Call
Dec 10, 2014
Q1 2015 Synergetics USA Inc Earnings Release
Nov 12, 2014
Synergetics USA Inc at Stephens Fall Investment Conference
Oct 14, 2014
Q4 2014 SYNERGETICS USA INC Earnings Call
Oct 14, 2014
Q4 2014 SYNERGETICS USA INC Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Oct '14) 2014
Net profit margin 4.61% 4.73%
Operating margin 6.95% 7.07%
EBITD margin - 11.43%
Return on average assets 3.59% 3.66%
Return on average equity 4.77% 4.92%
Employees 395 -
CDP Score - -

Address

3845 Corporate Centre Drive
O'FALLON, MO 63368
United States - Map
+1-636-9395100 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Synergetics USA, Inc. (Synergetics USA) is a supplier of precision surgical devices. The Company�s primary focus is on the disciplines of ophthalmology and neurosurgery. The Company�s product lines focus upon precision engineered, disposable and reusable devices, surgical equipment, procedural kits and the delivery of various energy modalities for the performance of surgery, including laser energy, ultrasonic energy, radio frequency energy for electrosurgery and lesion generation and visible light energy for illumination, and where applicable, simultaneous infusion (irrigation) of fluids into the operative field. In July 2013, its indirect subsidiary, Synergetics Surgical EU Ltd, acquired M.I.S.S. Ophthalmics Limited (M.I.S.S.). It also offers a portfolio of surgical products for the ophthalmic and aesthetics markets.

Officers and directors

David M. Hable President, Chief Executive Officer, Director
Age: 58
Bio & Compensation  - Reuters
Pamela G. Boone Chief Financial Officer, Executive Vice President, Treasurer, Secretary
Age: 47
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Michael R. Fanning Vice President - Domestic Sales
Age: 47
Bio & Compensation  - Reuters
Jason J. Stroisch Vice President - Marketing and Technology
Age: 38
Bio & Compensation  - Reuters
Robert H. Blankemeyer Independent Director
Age: 67
Bio & Compensation  - Reuters
Lawrence C. Cardinale Independent Director
Age: 75
Bio & Compensation  - Reuters
Juanita H. Hinshaw Independent Director
Age: 69
Bio & Compensation  - Reuters
D. Graeme Thomas Independent Director
Age: 75
Bio & Compensation  - Reuters